We can hypothesize that the wound healing-dependent activation of immune response in cryo-ablated tumour tissue can synergize with immune checkpoint inhibition such as anti-CTLA-4/ipilimumab therapy of melanoma. Here, CTLA4 is linked to neoplasm.